Vectoris Pharma Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Vectoris Pharma General Information

Description

Developer of pharmaceuticals products. The company develops needle-free, non-inhaled insulin delivery technology which involves suspension of macro-molecular drugs, such as insulin to facilitate systemic delivery via the buccal membrane.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Acquirer
PharmaDerm
Corporate Office
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vectoris Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vectoris Pharma‘s full profile, request access.

Request a free trial

Vectoris Pharma FAQs

  • Where is Vectoris Pharma headquartered?

    Vectoris Pharma is headquartered in .

  • What industry is Vectoris Pharma in?

    Vectoris Pharma’s primary industry is Drug Delivery.

  • Is Vectoris Pharma a private or public company?

    Vectoris Pharma is a Private company.

  • What is Vectoris Pharma’s current revenue?

    The current revenue for Vectoris Pharma is 000000.

  • When was Vectoris Pharma acquired?

    Vectoris Pharma was acquired on 29-Apr-2008.

  • Who acquired Vectoris Pharma?

    Vectoris Pharma was acquired by PharmaDerm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »